A Phase II Clinical Trial of Nedaplatin and Amurubicin Therapy for Advanced and Recurrent Squamous Cell Lung Cancer.
Phase of Trial: Phase II
Latest Information Update: 12 May 2016
At a glance
- Drugs Amrubicin (Primary) ; Nedaplatin (Primary)
- Indications Lung cancer
- Focus Therapeutic Use
- 03 Apr 2012 New trial record